Clinical Trial Update: Interventions for Reading Disabilities in NF1 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating interventions for reading disabilities in Neurofibromatosis Type 1 is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Learning Disability
• Neurofibromatosis Type
• Reading Disability

Snippet

Sponsor: Vanderbilt University | Conditions: Neurofibromatosis Type 1, Learning Disability | Phase 2 | Status: ACTIVE_NOT_RECRUITING